Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Psylo logo — Psychedelic-inspired medicine to treat mental illness

Psylo

Psychedelic-inspired medicine to treat mental illness

Founded 2021 Australia Australia 27 employees Seed Total: $14.10M Biotechnology

General Information

Company Name Psylo
Founded Year 2021
Location Australia Australia +1
Employees 27
Industries Biotechnology
Funding Stage Seed
Social

Get notified when Psylo moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Psylo

Psylo is a biotechnology startup founded in 2021 and headquartered in Australia. The company's slogan, "Psychedelic-inspired medicine to treat mental illness," reflects its focus on developing next-generation psychedelics as improved treatments for mental illness, aiming to provide alternatives to currently available SSRI medications. Psylo is actively engaged in drug development, with a specific emphasis on creating a pipeline of novel molecules. The ultimate goal is to advance leading candidates through to clinical trials. In its latest funding round on 27 October 2022, Psylo successfully secured a $5.00M investment from a consortium of notable backers, including Empath Ventures, Main Sequence Ventures, Lionheart Ventures, Negev Capital, CaraMed Capital, and UNSW Founders. This substantial investment signifies a strong vote of confidence in Psylo's vision and potential impact within the biotechnology and mental health treatment industries. As the company continues to progress and innovate, its ability to attract significant backing underscores its position as a promising player in the evolving landscape of psychedelic medicine.

Taxonomy: drug development, psychedelics, mental illness, medication, SSRI, clinical trials, pharmaceuticals, psychedelic medicine, novel molecules, mental health, treatment, psychiatry, innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 7
Investor Investor Investor Investor Investor Investor Investor
03 Jun 2024
Seed Round •••••• 3
Investor Investor Investor
27 Oct 2022
Seed Round •••••• - 01 Oct 2021

Psylo Alternatives & Competitors

Psylo vs
CB Therapeutics
CB Therapeutics United States

CB Therapeutics produces high value molecules, compounds and rare ingredients with novel, proprietar...

Series A
15 employees
Biotechnology, Health and Wellness
Compare Psylo vs CB Therapeutics
Psylo vs
Tactogen
Tactogen United States

Effective prescription mental wellness. For everyone.

Seed
4 employees
Biopharma, Biotechnology
Compare Psylo vs Tactogen
Psylo vs
Psy Therapeutics
Psy Therapeutics United States

Creating new futures in central nervous system (CNS) treatment and care.

Seed
11 employees
Biotechnology, Health Care
Compare Psylo vs Psy Therapeutics

FAQ About Psylo

Psychedelic-inspired medicine to treat mental illness
Psylo was founded in 2021.
Psylo is headquartered in Australia.
Psylo operates in the following industries: Biotechnology.
Psylo has approximately 27 employees.
Psylo has completed 3 funding rounds, raising a total of $14.10M. The latest funding stage is Seed.
Top alternatives and competitors to Psylo include CB Therapeutics, Tactogen, Psy Therapeutics, Lento Bio, SupraSensor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Psylo and CB Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Psylo and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes